walgreens boots alliance is the first global pharmacy-led, health and wellbeing enterprise. the company was created through the combination of walgreens and alliance boots in december 2014, bringing together two leading companies with iconic brands, complementary geographic footprints, shared values and a heritage of trusted health care services through pharmaceutical wholesaling and community pharmacy care, dating back more than 100 years. the company employs more than 370,000* people and has a presence in more than 25* countries; it is the largest retail pharmacy, health and daily living destination in the usa and europe. including its equity method investments, walgreens boots alliance is a global leader in pharmacy-led, health and wellbeing retail with over 13,100* stores in 11* countries. the company includes one of the largest global pharmaceutical wholesale and distribution networks with over 350* distribution centers delivering to more than 200,000** pharmacies, doctors, he
Company profile
Ticker
WBA, WBA-MM
Exchange
Website
CEO
Stefano Pessina
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Walgreens Arizona Drug Co. • Village Practice Management Company, LLC • Walgreen Investments Co • Walgreens Boots Alliance Holdings LLC • Walgreens Specialty Pharmacy, LLC • WBA Investments, Inc. • WBA US 26 LLC • Summit CityMD Midco, LLC • Bond Drug Company • Walgreen Co. ...
WBA stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
28 Mar 24
10-Q
2024 Q2
Quarterly report
28 Mar 24
8-K
Walgreens Boots Alliance Reports Fiscal 2024 Second Quarter Results
28 Mar 24
8-K
Walgreens Boots Alliance Announces Leadership Appointments
8 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
31 Jan 24
10-Q
2024 Q1
Quarterly report
4 Jan 24
8-K
Walgreens Boots Alliance Reports Fiscal 2024 First Quarter Results
4 Jan 24
PX14A6G
Letter to shareholders
22 Dec 23
PX14A6G
Letter to shareholders
11 Dec 23
ARS
2023 FY
Annual report to shareholders
8 Dec 23
Transcripts
WBA
Earnings call transcript
2024 Q2
28 Mar 24
WBA
Earnings call transcript
2024 Q1
4 Jan 24
WBA
Earnings call transcript
2023 Q4
12 Oct 23
WBA
Earnings call transcript
2023 Q3
27 Jun 23
WBA
Earnings call transcript
2023 Q2
28 Mar 23
WBA
Earnings call transcript
2023 Q1
5 Jan 23
WBA
Earnings call transcript
2022 Q4
13 Oct 22
WBA
Earnings call transcript
2022 Q3
30 Jun 22
WBA
Earnings call transcript
2022 Q2
31 Mar 22
WBA
Earnings call transcript
2022 Q1
6 Jan 22
Latest ownership filings
Financial summary
Quarter (USD) | Nov 23 | Aug 23 | May 23 | Feb 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Aug 23 | Aug 22 | Aug 21 | Aug 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 846.00 mm | 846.00 mm | 846.00 mm | 846.00 mm | 846.00 mm | 846.00 mm |
Cash burn (monthly) | 3.33 mm | 289.00 mm | 119.33 mm | 56.58 mm | 93.67 mm | (no burn) |
Cash used (since last report) | 15.54 mm | 1.35 bn | 556.47 mm | 263.86 mm | 436.78 mm | n/a |
Cash remaining | 830.46 mm | -501.64 mm | 289.53 mm | 582.14 mm | 409.22 mm | n/a |
Runway (months of cash) | 249.1 | -1.7 | 2.4 | 10.3 | 4.4 | n/a |
Institutional ownership, Q3 2023
73.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1018 |
Opened positions | 116 |
Closed positions | 200 |
Increased positions | 359 |
Reduced positions | 406 |
13F shares | Current |
---|---|
Total value | 10.93 tn |
Total shares | 632.95 mm |
Total puts | 15.85 mm |
Total calls | 16.96 mm |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Alliance Sante Participations | 144.79 mm | $5.84 bn |
Vanguard | 86.68 mm | $1.93 tn |
BLK Blackrock | 66.03 mm | $1.47 tn |
STT State Street | 54.24 mm | $1.21 tn |
IVZ Invesco | 17.03 mm | $378.67 bn |
Geode Capital Management | 16.14 mm | $358.27 bn |
Capital World Investors | 14.29 mm | $317.71 bn |
MS Morgan Stanley | 12.58 mm | $279.88 bn |
NTRS Northern Trust | 7.70 mm | $171.32 bn |
ProShare Advisors | 6.94 mm | $154.37 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Apr 24 | Inderpal S Bhandari | Common Stock | Buy | Acquire P | No | No | 18.05 | 3,000 | 54.15 k | 3,000 |
2 Apr 24 | Manmohan Mahajan | Common Stock | Buy | Acquire P | No | No | 19.38 | 6,000 | 116.28 k | 166,969 |
1 Mar 24 | Manmohan Mahajan | Common Stock | Grant | Acquire A | No | No | 0 | 101,874 | 0.00 | 160,969 |
News
Tommy Tuberville Trades Raise Eyebrows Again: Senator Sells Put Options, Buys Small Biotech Linked To Ukraine-Russia War
17 Apr 24
Insiders Buying Walgreens And 2 Other Stocks
16 Apr 24
Behind the Scenes of Walgreens Boots Alliance's Latest Options Trends
11 Apr 24
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
5 Apr 24
Deutsche Bank Maintains Hold on Walgreens Boots Alliance, Lowers Price Target to $22
3 Apr 24
Press releases
Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday April 27
18 Apr 24
Foundation for Sarcoidosis Research and Walgreens Unite in Alabama to Boost Sarcoidosis Awareness and Spring Vaccine Education for April Awareness Month
15 Apr 24
Walgreens Boots Alliance Reports Fiscal 2024 Second Quarter Results
28 Mar 24
CLAIRE'S ANNOUNCES NATIONAL LAUNCH IN WALGREENS
12 Mar 24
Walgreens Boots Alliance Schedules Fiscal 2024 Second Quarter Earnings Announcement for March 28
4 Mar 24